95 related articles for article (PubMed ID: 21067605)
1. Abnormal iron metabolism in fibroblasts from a patient with the neurodegenerative disease hereditary ferritinopathy.
Barbeito AG; Levade T; Delisle MB; Ghetti B; Vidal R
Mol Neurodegener; 2010 Nov; 5():50. PubMed ID: 21067605
[TBL] [Abstract][Full Text] [Related]
2. Iron-mediated aggregation and a localized structural change characterize ferritin from a mutant light chain polypeptide that causes neurodegeneration.
Baraibar MA; Barbeito AG; Muhoberac BB; Vidal R
J Biol Chem; 2008 Nov; 283(46):31679-89. PubMed ID: 18755684
[TBL] [Abstract][Full Text] [Related]
3. A mutant light-chain ferritin that causes neurodegeneration has enhanced propensity toward oxidative damage.
Baraibar MA; Barbeito AG; Muhoberac BB; Vidal R
Free Radic Biol Med; 2012 May; 52(9):1692-7. PubMed ID: 22348978
[TBL] [Abstract][Full Text] [Related]
4. Heterozygous Nonsense Variants in the Ferritin Heavy Chain Gene
Shieh JT; Tintos-Hernández JA; Murali CN; Penon-Portmann M; Flores-Mendez M; Santana A; Bulos JA; Du K; Dupuis L; Damseh N; Mendoza-Londoño R; Berera C; Lee JC; Phillips JJ; Alves CAPF; Dmochowski IJ; Ortiz-González XR
medRxiv; 2023 Jan; ():. PubMed ID: 36778397
[TBL] [Abstract][Full Text] [Related]
5. Neuroferritinopathy: iron in the brain.
Burn J
Mol Cytogenet; 2014; 7(Suppl 1 Proceedings of the International Conference on Human):I36. PubMed ID: 24949097
[No Abstract] [Full Text] [Related]
6. Exploratory Analysis of Image-Guided Ionizing Radiation Delivery to Induce Long-Term Iron Accumulation and Ferritin Expression in a Lung Injury Model: Preliminary Results.
Zaher A; Duchman B; Ivanovic M; Spitz DR; Furqan M; Allen BG; Petronek MS
Bioengineering (Basel); 2024 Feb; 11(2):. PubMed ID: 38391668
[TBL] [Abstract][Full Text] [Related]
7. FLCN regulates transferrin receptor 1 transport and iron homeostasis.
Wang X; Wu H; Zhao L; Liu Z; Qi M; Jin Y; Liu W
J Biol Chem; 2021; 296():100426. PubMed ID: 33609526
[TBL] [Abstract][Full Text] [Related]
8. Pathogenic mechanism and modeling of neuroferritinopathy.
Cozzi A; Santambrogio P; Ripamonti M; Rovida E; Levi S
Cell Mol Life Sci; 2021 Apr; 78(7):3355-3367. PubMed ID: 33439270
[TBL] [Abstract][Full Text] [Related]
9. Mitochondrial Dysfunction, Oxidative Stress and Neuroinflammation in Neurodegeneration with Brain Iron Accumulation (NBIA).
Hinarejos I; Machuca-Arellano C; Sancho P; Espinós C
Antioxidants (Basel); 2020 Oct; 9(10):. PubMed ID: 33092153
[TBL] [Abstract][Full Text] [Related]
10. Iron, Ferritin, Hereditary Ferritinopathy, and Neurodegeneration.
Muhoberac BB; Vidal R
Front Neurosci; 2019; 13():1195. PubMed ID: 31920471
[TBL] [Abstract][Full Text] [Related]
11. DMT1 Expression and Iron Levels at the Crossroads Between Aging and Neurodegeneration.
Ingrassia R; Garavaglia B; Memo M
Front Neurosci; 2019; 13():575. PubMed ID: 31231185
[TBL] [Abstract][Full Text] [Related]
12. Neurodegeneration with Brain Iron Accumulation Disorders: Valuable Models Aimed at Understanding the Pathogenesis of Iron Deposition.
Levi S; Tiranti V
Pharmaceuticals (Basel); 2019 Feb; 12(1):. PubMed ID: 30744104
[TBL] [Abstract][Full Text] [Related]
13. Emerging and Dynamic Biomedical Uses of Ferritin.
Chiou B; Connor JR
Pharmaceuticals (Basel); 2018 Nov; 11(4):. PubMed ID: 30428583
[TBL] [Abstract][Full Text] [Related]
14. Impaired Transferrin Receptor Palmitoylation and Recycling in Neurodegeneration with Brain Iron Accumulation.
Drecourt A; Babdor J; Dussiot M; Petit F; Goudin N; Garfa-Traoré M; Habarou F; Bole-Feysot C; Nitschké P; Ottolenghi C; Metodiev MD; Serre V; Desguerre I; Boddaert N; Hermine O; Munnich A; Rötig A
Am J Hum Genet; 2018 Feb; 102(2):266-277. PubMed ID: 29395073
[TBL] [Abstract][Full Text] [Related]
15. Effect of Systemic Iron Overload and a Chelation Therapy in a Mouse Model of the Neurodegenerative Disease Hereditary Ferritinopathy.
Garringer HJ; Irimia JM; Li W; Goodwin CB; Richine B; Acton A; Chan RJ; Peacock M; Muhoberac BB; Ghetti B; Vidal R
PLoS One; 2016; 11(8):e0161341. PubMed ID: 27574973
[TBL] [Abstract][Full Text] [Related]
16. Neuroferritinopathy: From ferritin structure modification to pathogenetic mechanism.
Levi S; Rovida E
Neurobiol Dis; 2015 Sep; 81():134-43. PubMed ID: 25772441
[TBL] [Abstract][Full Text] [Related]
17. A novel neuroferritinopathy mouse model (FTL 498InsTC) shows progressive brain iron dysregulation, morphological signs of early neurodegeneration and motor coordination deficits.
Maccarinelli F; Pagani A; Cozzi A; Codazzi F; Di Giacomo G; Capoccia S; Rapino S; Finazzi D; Politi LS; Cirulli F; Giorgio M; Cremona O; Grohovaz F; Levi S
Neurobiol Dis; 2015 Sep; 81():119-33. PubMed ID: 25447222
[TBL] [Abstract][Full Text] [Related]
18. Short communication: high cellular iron levels are associated with increased HIV infection and replication.
Chang HC; Bayeva M; Taiwo B; Palella FJ; Hope TJ; Ardehali H
AIDS Res Hum Retroviruses; 2015 Mar; 31(3):305-12. PubMed ID: 25291189
[TBL] [Abstract][Full Text] [Related]
19. New perspectives on oxidized genome damage and repair inhibition by pro-oxidant metals in neurological diseases.
Mitra J; Guerrero EN; Hegde PM; Wang H; Boldogh I; Rao KS; Mitra S; Hegde ML
Biomolecules; 2014 Jul; 4(3):678-703. PubMed ID: 25036887
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
